Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes

Kazutaka Ohi, Ryota Hashimoto, Masashi Ikeda, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Satomi Umeda-Yano, Masaki Fukunaga, Haruo Fujino, Yoshiyuki Watanabe, Masao Iwase, Hiroaki Kazui, Nakao Iwata, Daniel R. Weinberger, Masatoshi Takeda

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Cognitive impairments are a core feature in patients with schizophrenia. These deficits could serve as effective tools for understanding the genetic architecture of schizophrenia. This study investigated whether genetic variants associated with cognitive impairments aggregate in functional gene networks related to the pathogenesis of schizophrenia. Here, genome-wide association studies (GWAS) of a range of cognitive phenotypes relevant to schizophrenia were performed in 411 healthy subjects. We attempted to replicate the GWAS data using 257 patients with schizophrenia and performed a meta-analysis of the GWAS findings and the replicated results. Because gene networks, rather than a single gene or genetic variant, may be strongly associated with the susceptibility to schizophrenia and cognitive impairments, gene-network analysis for genes in close proximity to the replicated variants was performed. We observed nominal associations between 3054 variants and cognitive phenotypes at a threshold of P < 1.0 × 10- 4. Of the 3054 variants, the associations of 191 variants were replicated in the replication samples (P <. 05). However, no variants achieved genome-wide significance in a meta-analysis (P > 5.0 × 10- 8). Additionally, 115 of 191 replicated single nucleotide polymorphisms (SNPs) have genes located within 10 kb of the SNPs (60.2%). These variants were moderately associated with cognitive phenotypes that ranged from P = 2.50 × 10- 5 to P = 9.40 × 10- 8. The genes located within 10 kb from the replicated SNPs were significantly grouped in terms of glutamate receptor activity (false discovery rate (FDR) q = 4.49 × 10- 17) and the immune system related to major histocompatibility complex class I (FDR q = 8.76 × 10- 11) networks. Our findings demonstrate that genetic variants related to cognitive trait impairment in schizophrenia are involved in the N-methyl-d-aspartate glutamate network.

Original languageEnglish
Pages (from-to)909-918
Number of pages10
JournalSchizophrenia Bulletin
Volume41
Issue number4
DOIs
Publication statusPublished - 01-07-2015

Fingerprint

Genome-Wide Association Study
Glutamic Acid
Schizophrenia
Phenotype
Gene Regulatory Networks
Single Nucleotide Polymorphism
Genes
Glutamate Receptors
Cognitive Dysfunction
Major Histocompatibility Complex
Aspartic Acid
Meta-Analysis
Immune System
Healthy Volunteers

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health

Cite this

Ohi, Kazutaka ; Hashimoto, Ryota ; Ikeda, Masashi ; Yamamori, Hidenaga ; Yasuda, Yuka ; Fujimoto, Michiko ; Umeda-Yano, Satomi ; Fukunaga, Masaki ; Fujino, Haruo ; Watanabe, Yoshiyuki ; Iwase, Masao ; Kazui, Hiroaki ; Iwata, Nakao ; Weinberger, Daniel R. ; Takeda, Masatoshi. / Glutamate Networks Implicate Cognitive Impairments in Schizophrenia : Genome-Wide Association Studies of 52 Cognitive Phenotypes. In: Schizophrenia Bulletin. 2015 ; Vol. 41, No. 4. pp. 909-918.
@article{7f5f1f1c82164953ae634b8b0b094d79,
title = "Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes",
abstract = "Cognitive impairments are a core feature in patients with schizophrenia. These deficits could serve as effective tools for understanding the genetic architecture of schizophrenia. This study investigated whether genetic variants associated with cognitive impairments aggregate in functional gene networks related to the pathogenesis of schizophrenia. Here, genome-wide association studies (GWAS) of a range of cognitive phenotypes relevant to schizophrenia were performed in 411 healthy subjects. We attempted to replicate the GWAS data using 257 patients with schizophrenia and performed a meta-analysis of the GWAS findings and the replicated results. Because gene networks, rather than a single gene or genetic variant, may be strongly associated with the susceptibility to schizophrenia and cognitive impairments, gene-network analysis for genes in close proximity to the replicated variants was performed. We observed nominal associations between 3054 variants and cognitive phenotypes at a threshold of P < 1.0 × 10- 4. Of the 3054 variants, the associations of 191 variants were replicated in the replication samples (P <. 05). However, no variants achieved genome-wide significance in a meta-analysis (P > 5.0 × 10- 8). Additionally, 115 of 191 replicated single nucleotide polymorphisms (SNPs) have genes located within 10 kb of the SNPs (60.2{\%}). These variants were moderately associated with cognitive phenotypes that ranged from P = 2.50 × 10- 5 to P = 9.40 × 10- 8. The genes located within 10 kb from the replicated SNPs were significantly grouped in terms of glutamate receptor activity (false discovery rate (FDR) q = 4.49 × 10- 17) and the immune system related to major histocompatibility complex class I (FDR q = 8.76 × 10- 11) networks. Our findings demonstrate that genetic variants related to cognitive trait impairment in schizophrenia are involved in the N-methyl-d-aspartate glutamate network.",
author = "Kazutaka Ohi and Ryota Hashimoto and Masashi Ikeda and Hidenaga Yamamori and Yuka Yasuda and Michiko Fujimoto and Satomi Umeda-Yano and Masaki Fukunaga and Haruo Fujino and Yoshiyuki Watanabe and Masao Iwase and Hiroaki Kazui and Nakao Iwata and Weinberger, {Daniel R.} and Masatoshi Takeda",
year = "2015",
month = "7",
day = "1",
doi = "10.1093/schbul/sbu171",
language = "English",
volume = "41",
pages = "909--918",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "4",

}

Ohi, K, Hashimoto, R, Ikeda, M, Yamamori, H, Yasuda, Y, Fujimoto, M, Umeda-Yano, S, Fukunaga, M, Fujino, H, Watanabe, Y, Iwase, M, Kazui, H, Iwata, N, Weinberger, DR & Takeda, M 2015, 'Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes', Schizophrenia Bulletin, vol. 41, no. 4, pp. 909-918. https://doi.org/10.1093/schbul/sbu171

Glutamate Networks Implicate Cognitive Impairments in Schizophrenia : Genome-Wide Association Studies of 52 Cognitive Phenotypes. / Ohi, Kazutaka; Hashimoto, Ryota; Ikeda, Masashi; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Umeda-Yano, Satomi; Fukunaga, Masaki; Fujino, Haruo; Watanabe, Yoshiyuki; Iwase, Masao; Kazui, Hiroaki; Iwata, Nakao; Weinberger, Daniel R.; Takeda, Masatoshi.

In: Schizophrenia Bulletin, Vol. 41, No. 4, 01.07.2015, p. 909-918.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Glutamate Networks Implicate Cognitive Impairments in Schizophrenia

T2 - Genome-Wide Association Studies of 52 Cognitive Phenotypes

AU - Ohi, Kazutaka

AU - Hashimoto, Ryota

AU - Ikeda, Masashi

AU - Yamamori, Hidenaga

AU - Yasuda, Yuka

AU - Fujimoto, Michiko

AU - Umeda-Yano, Satomi

AU - Fukunaga, Masaki

AU - Fujino, Haruo

AU - Watanabe, Yoshiyuki

AU - Iwase, Masao

AU - Kazui, Hiroaki

AU - Iwata, Nakao

AU - Weinberger, Daniel R.

AU - Takeda, Masatoshi

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Cognitive impairments are a core feature in patients with schizophrenia. These deficits could serve as effective tools for understanding the genetic architecture of schizophrenia. This study investigated whether genetic variants associated with cognitive impairments aggregate in functional gene networks related to the pathogenesis of schizophrenia. Here, genome-wide association studies (GWAS) of a range of cognitive phenotypes relevant to schizophrenia were performed in 411 healthy subjects. We attempted to replicate the GWAS data using 257 patients with schizophrenia and performed a meta-analysis of the GWAS findings and the replicated results. Because gene networks, rather than a single gene or genetic variant, may be strongly associated with the susceptibility to schizophrenia and cognitive impairments, gene-network analysis for genes in close proximity to the replicated variants was performed. We observed nominal associations between 3054 variants and cognitive phenotypes at a threshold of P < 1.0 × 10- 4. Of the 3054 variants, the associations of 191 variants were replicated in the replication samples (P <. 05). However, no variants achieved genome-wide significance in a meta-analysis (P > 5.0 × 10- 8). Additionally, 115 of 191 replicated single nucleotide polymorphisms (SNPs) have genes located within 10 kb of the SNPs (60.2%). These variants were moderately associated with cognitive phenotypes that ranged from P = 2.50 × 10- 5 to P = 9.40 × 10- 8. The genes located within 10 kb from the replicated SNPs were significantly grouped in terms of glutamate receptor activity (false discovery rate (FDR) q = 4.49 × 10- 17) and the immune system related to major histocompatibility complex class I (FDR q = 8.76 × 10- 11) networks. Our findings demonstrate that genetic variants related to cognitive trait impairment in schizophrenia are involved in the N-methyl-d-aspartate glutamate network.

AB - Cognitive impairments are a core feature in patients with schizophrenia. These deficits could serve as effective tools for understanding the genetic architecture of schizophrenia. This study investigated whether genetic variants associated with cognitive impairments aggregate in functional gene networks related to the pathogenesis of schizophrenia. Here, genome-wide association studies (GWAS) of a range of cognitive phenotypes relevant to schizophrenia were performed in 411 healthy subjects. We attempted to replicate the GWAS data using 257 patients with schizophrenia and performed a meta-analysis of the GWAS findings and the replicated results. Because gene networks, rather than a single gene or genetic variant, may be strongly associated with the susceptibility to schizophrenia and cognitive impairments, gene-network analysis for genes in close proximity to the replicated variants was performed. We observed nominal associations between 3054 variants and cognitive phenotypes at a threshold of P < 1.0 × 10- 4. Of the 3054 variants, the associations of 191 variants were replicated in the replication samples (P <. 05). However, no variants achieved genome-wide significance in a meta-analysis (P > 5.0 × 10- 8). Additionally, 115 of 191 replicated single nucleotide polymorphisms (SNPs) have genes located within 10 kb of the SNPs (60.2%). These variants were moderately associated with cognitive phenotypes that ranged from P = 2.50 × 10- 5 to P = 9.40 × 10- 8. The genes located within 10 kb from the replicated SNPs were significantly grouped in terms of glutamate receptor activity (false discovery rate (FDR) q = 4.49 × 10- 17) and the immune system related to major histocompatibility complex class I (FDR q = 8.76 × 10- 11) networks. Our findings demonstrate that genetic variants related to cognitive trait impairment in schizophrenia are involved in the N-methyl-d-aspartate glutamate network.

UR - http://www.scopus.com/inward/record.url?scp=84988267086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988267086&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbu171

DO - 10.1093/schbul/sbu171

M3 - Article

C2 - 25537281

AN - SCOPUS:84988267086

VL - 41

SP - 909

EP - 918

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 4

ER -